Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15460,36,1.58 [1.12-2.22],0.0095155389509366
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Alcohol dependence,18116,98,0.38 [0.20-0.72],0.0029905049697141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,18446,135,0.50 [0.31-0.82],0.0063301824016823
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,19438,99,1.46 [1.14-1.87],0.0030334625439414
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19233,211,1.33 [1.09-1.63],0.0057930573247372
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18760,134,1.46 [1.16-1.83],0.0010725245943739
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18744,118,1.46 [1.15-1.86],0.0016294216232299
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19665,111,1.49 [1.17-1.89],0.0010470111190906
